A study of swelling reducing property of Homoeopathic medicine TINOSPORA CORDIFOLIA under laboratory setting with clinical study of the same in Arthropathy patients.

In Vitro Study of anti-inflammatory activity of Homoeopathic medicine TINOSPORA CORDIFOLIA and clinical verification in Rheumatoid Arthritis patients-A Randomized controlled clinical trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075639

Enrollment

Registered

2024-10-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M056- Rheumatoid arthritis with involvement of other organs and systems

Interventions

Intervention1: TINOSPORA CORDIFOLIA: TINOSPORA CORDIFOLIA will be given in 40 size globules 4 globules twice a day for 2 weeks Control Intervention1: HOMOEOPATHIC MEDICINE: Individualised Homoeopathic

Eligibility

Inclusion criteria

Inclusion criteria: 1.Those patients satisfying 2010 ACR/EULAR criteria for Rheumatoid Arthritis 2.Subjects belonging to both sexes 3.Patients belonging to the age group 20-70 years

Exclusion criteria

Exclusion criteria: 1.Cases associated with malignancies, renal failure, hepatic failure. 2.Pregnant females 3.Cases with disease activity score 28 more than 7.5(high disease activity)

Design outcomes

Primary

Measure	Time frame
1)Study Title:To assess anti-inflammatory activity. Description:By assessing Percentage of inhibition Interval:48 hours 2)Clinical study Title:To assess the reduction in Disease Activity Score 28 Description:Disease Activity Score 28 final value - Disease Activity Score 28 initial value Interval:3months Timepoint: 1)Study Title:To assess anti-inflammatory activity. Description:By assessing Percentage of inhibition Interval:48 hours 2)Clinical study Title:To assess the reduction in Disease Activity Score 28 Description:Disease Activity Score 28 final value - Disease Activity Score 28 initial value Interval:3months	—

Measure

Time frame

1)Study Title:To assess anti-inflammatory activity. Description:By assessing Percentage of inhibition Interval:48 hours 2)Clinical study Title:To assess the reduction in Disease Activity Score 28 Description:Disease Activity Score 28 final value - Disease Activity Score 28 initial value Interval:3months Timepoint: 1)Study Title:To assess anti-inflammatory activity. Description:By assessing Percentage of inhibition Interval:48 hours 2)Clinical study Title:To assess the reduction in Disease Activity Score 28 Description:Disease Activity Score 28 final value - Disease Activity Score 28 initial value Interval:3months

—

Secondary

Measure	Time frame
Comparison of Therapeutic effectiveness of Homoeopathic medicine Tinospora cordifolia & Homoeopathic constitutional medicines among the groupTimepoint: After 1 year(after completion of the study)	—

Countries

India

Contacts

Public ContactDr Jaya C

Government Homoeopathic Medical College Kozhikode

drjayakishan@gmail.com9446529775

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026